Law - Compliance With Sequence Listing Rules

Patent applications which contain disclosures of nucleotide and/or amino acid sequences must contain a listing of the sequences in a specified format. If a review of the patent application reveals that the format rules have not been complied with by the applicant, he/she will be sent a notice detailing the deficiency and given a period of at least 1 month for response. It is important to note that the response cannot contain any "new matter." Therefore, the application as filed must provide adequate support for any information supplied later in order to comply with the sequence listing format rules.

The position of the USPTO on this issue is described in the following section(s) of the Manual of Patent Examining Procedure (MPEP):

MPEP 2422.03 - The Requirements for a Sequence Listing and Sequence Identifiers; Sequences Embedded in Application Text; Variants of a Presented Sequence
MPEP 2422.07 - Requirements for Compliance, Statements Regarding New Matter, and Sanctions for Failure to Comply

Return to Home

© 1998-2003 Robert M. Hunter PLLC